List of PPS Fill Finish Service Providers · GlobeNewswire Inc. Location of Manufacturing Location of Manufacturing · GlobeNewswire Inc. Number of Barrel Chambers Number of Barrel Chambers · ...

DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringe Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The future of the prefilled ...

DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringe Fill / Finish Services Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. This report features an extensive study of the ...

Among drug delivery devices, prefilled syringes represent one of the fastest growing primary packaging formats, which are also designed for dose administration. In fact, over the past ten years, there ...

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...

The prefilled syringe is provided as a 300mg/2mL (150mg/mL) ready-to-use solution for subcutaneous injection and does not require additional reconstitution or dilution. Takhzyro ® (lanadelumab-flyo) ...

(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the prefilled syringe fill finish manufacturing market include an increased demand for safer, user-friendly administration technologies, a ...

(RTTNews) - ANI Pharmaceuticals Inc. (ANIP) announced that the U.S. Food and Drug Administration approved Purified Cortrophin Gel (repository corticotropin injection USP) (Cortrophin Gel) in a ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a prefilled syringe presentation to prevent shingles (herpes zoster). This ...

Apellis Pharmaceuticals recently presented at the 44th Annual J.P. Morgan Healthcare Conference, outlining 2025 performance highlights and pipeline progress, including continued demand growth for ...

SAN DIEGO, CA—Patients with acute gouty arthritis who received canakinumab administered via a prefilled syringe experienced significantly greater pain relief and reduced risk of new attacks compared ...